Actively Recruiting
Restricted Eating Time in the Treatment of Type 2 Diabetes
Led by Steno Diabetes Center Copenhagen · Updated on 2025-05-16
160
Participants Needed
1
Research Sites
110 weeks
Total Duration
On this page
Sponsors
S
Steno Diabetes Center Copenhagen
Lead Sponsor
U
University of Leeds
Collaborating Sponsor
AI-Summary
What this Trial Is About
The overall aim of the present study is to investigate the effectiveness of implementing a 1-year time-restricted eating (TRE)-based intervention on glycaemic control, body weight and composition, cardiometabolic risk factors, and behaviour in individuals with overweight/obesity and type 2 diabetes (T2D).
CONDITIONS
Official Title
Restricted Eating Time in the Treatment of Type 2 Diabetes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Overweight or obesity with BMI 25 kg/m2 or higher
- Diagnosis of type 2 diabetes with HbA1c greater than 53 mmol/mol
- Habitual eating window of 12 hours or more per day including food, snacks, and calorie-containing beverages
You will not qualify if you...
- History of or planned bariatric surgery during the study
- Use of fast acting insulin or combination insulin products
- Regular use of continuous glucose monitoring (CGM)
- Desire to observe Ramadan fasting
- Current or planned pregnancy or breastfeeding
- Alcohol or drug abuse or treatment with disulfiram
- Severe hypoglycaemia in the past year requiring external help
- Inability to understand Danish language
- Unable or unwilling to follow the time-restricted eating plan
- Medical conditions that limit participation including severe heart, lung, vascular, cancer, psychiatric, gastrointestinal, rheumatic, or endocrine diseases
- Participation in other intervention studies
- Severe vision or hearing impairment affecting neuropsychological testing
- Contraindications to MRI or unwillingness to receive MRI incidental findings (for sub-study participants)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Steno Diabetes Center Copenhagen
Herlev, Denmark, Denmark, 2730
Actively Recruiting
Research Team
J
Jonas S Quist, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here